Moxifloxacin
Back to searchMolecule Structure
Scientific Name
Moxifloxacin
Description of the Drug
Moxifloxacin is a fluoroquinolone antibiotic used to treat various bacterial infections.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00218
http://www.drugbank.ca/drugs/DB00218
Brand Name(s)
Avelox, Avelox i.v.
Company Owner(s)
Sunshine Lake Pharma Co Ltd, Mylan Pharmaceuticals Inc, Novartis Pharmaceuticals Corp, Akorn Operating Co Llc, Torrent Pharmaceuticals Ltd, Indoco Remedies Ltd, Imprimis Pharmaceuticals Usa Llc, Fresenius Kabi Usa Llc, Upsher Smith Laboratories Llc, Aurobindo Pharma Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Bacterial DNA gyrase | PROTEIN COMPLEX | INHIBITOR | CHEMBL2311224 |
| Topoisomerase IV | PROTEIN COMPLEX | INHIBITOR | CHEMBL2363076 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL24007 | ||||
| PharmGKB | PA450555 | ||||
| Human Metabolome Database | HMDB0014363 | ||||
| DrugBank | DB00218 | ||||
| PubChem: Thomson Pharma | 14781355 | 14757114 | |||
| PubChem | 40467042 | 152946 | |||
| LINCS | LSM-5746 | ||||
| Nikkaji | J1.495.215B | ||||
| PDBe | MFX | ||||
| BindingDB | 50366824 | ||||
| EPA CompTox Dashboard | DTXSID3048491 | ||||
| DrugCentral | 1854 | ||||
| Brenda | 13727 | ||||
| Guide to Pharmacology | 10915 | ||||
| rxnorm | MOXIFLOXACIN HYDROCHLORIDE | VIGAMOX | MOXIFLOXACIN | MOXEZA | AVELOX |
| ChEBI | 63611 | ||||
| ZINC | ZINC000003826253 |
